(Q45025588)

English

Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

anti-retroviral agent

0 references

Hoda Anton-Culver

5

object named as

Hoda Anton-Culver

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Catherine Diamond

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Thomas H Taylor

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Theresa Im

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Mohammed Miradi

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

139-145

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

21 January 2018

Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDS across Europe, 1994-98: the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Karnofsky performance status revisited: reliability, validity, and guidelines

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FHON.778

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.778

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45025588&oldid=2062699831"